Clinical Trials Browser

Phase 2 × Melanoma × Ramucirumab × Clear all

NCT00533702 2014-08-01

A Study of IMC-1121B (Ramucirumab) With or Without Dacarbazine in Metastatic Malignant Melanoma

Phase 2 Completed

106 enrolled 15 charts

Melanoma